Australia

Patrys Limited develops therapies for the capture, production, and development of natural human antibodies as therapies for cancer and other diseases.

Bionomics Limited operates as a biotechnology company, which specializes in the genetics field.  The Company, which is affiliated with a number of research institutions, seeks to develop a variety of genomic, genetic, molecular and cell biology techniques, which they believe will help demonstrate the onset and progression of diseases like epilepsy and breast cancer.

Bioxyne  Limited operates as a biotechnology company.  The Company specializes in the research, development and commercialization of diseases related to chronic obstructive pulmonary disease(COPD).

Regeneus Ltd is a regenerative medicine company focused on using the regenerative capacities of adipose-derived cells to develop innovative cell therapies for humans and animals.

Anatara Lifesciences Limited operates in the field of biological sciences. The Company develops non-antibiotic oral solutions for gastrointestinal diseases in animals and humans.

Nanollose Limited operates as a bio-technology company. The Company discovers and develops intellectual property based on novel products and processes related to microbial nanocellulose. Nanollose uses industrial organic and agricultural waste products to produce cellulose. Nanollose serves clients in Australia.

BPH Global Ltd is a bio-technology company. The Company focuses on the growth, reproduction, culture, and extraction of stem cells for medicinal, health and beauty applications using proprietary technology.

Vectus Biosystems Limited operates as a biotechnology company. The Company offers pre-clinical substantial animal and human cell toxicity testing services. Vectus Biosystems conducts its business in Australia.

Biotron Limited specializes in the funding, management and commercialization of biomedical projects that result from research conducted at the John Curtin School of Medical Research, a research institute within the Australian National University.  The Group conducts diagnostic and therapeutic research with the intention of creating compounds and diagnostics that can be sold or licensed.

Immuron Limited operates as a biopharmaceutical company. The Company focuses on oral immunotherapy utilizing polyclonal antibody products that target the human gut immune system and gut microbiome. Immuron's technology platform is developing and producing an orally stable therapeutic for various immune mediated and inflammatory disorders.

Bellicum Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company focuses on discovering and developing novel cellular immunotherapies for cancer, tumors, and blood diseases. Bellicum Pharmaceuticals serves patients in the United States.

Navidea Biopharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of precision radiopharmaceutical diagnostics for diseases such as cancer.

Aravive, Inc. operates as a biotechnology company. The Company develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders. Aravive serves patients in the United States.

Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It offer tests for disorders in cardiovascular, hereditary cancer, neurology, pediatrics, and other rare diseases. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA.

Salarius Pharmaceuticals Inc is a clinical-stage oncology company. The Company specializes in targeting the epigenetic causes of cancers and developing treatments for patients. Salarius Pharmaceuticals serves patients and customers in the State of Texas.

Trevena, Inc. develops pharmaceutical products. The Company offers discovery and development of agents targeting G-protein coupled receptors and therapies and drugs that treat acute heart failure, acute chronic pain, and depression. Trevena serves customers throughout the United States.

Sorrento Therapeutics, Inc. is a biopharmaceutical company. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic, and infectious diseases.

Otonomy, Inc. operates as a clinical stage biopharmaceutical company. The Company develops therapeutics for treatment of inner and middle ear disorders.

Organovo Holdings, Inc. operates as a biology company. The Company focuses on bio-printing technology and creating tissues for research and medical applications.

Hybrigenics S.A. is a biotechnology and pharmaceutical company. The Company develops therapeutics against cancer as well as develops platforms to identify, validate and inhibit protein interactions.

DorsaVi Ltd. develops and sells wireless sensor movement monitoring systems. The Company's technology is used by the to monitor workplace and sports related injury and pain.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00